D.C. Mun. Regs. tit. 29, r. 29-6264

Current through Register Vol. 71, No. 49, December 6, 2024

Rule 29-6264 - THERAPEUTIC USE OF PSYCHOTROPIC MEDICATIONS

6264.1

If psychotropic medication is prescribed, the facility shall cooperate with the contracting entity and, where applicable, the CSSD to obtain a written report from the prescribing physician detailing:

(a) The type of medication;

(b) The dosage;

(c) The necessity for the medication;

(d) The resident's other medications and the effect of their interaction;

(e) The staff monitoring requirements, if any;

(f) Potential side effects;

(g) The next scheduled clinical meeting; and

(h) A current therapeutic treatment plan or behavioral management plan.

6264.2

The facility shall cooperate with the contracting entity and, where applicable, the CSSD to obtain written consent from the resident's parent(s) or guardian(s), or court order, before administering psychotropic medications.

6264.3

The facility shall document the prescription and administration of medication, and notify attending physicians of, and record, significant changes in a resident's behavior or health.

D.C. Mun. Regs. tit. 29, r. 29-6264

Final Rulemaking published at 48 DCR 8675, 8729 (September 21, 2001)